| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |